Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Slated to Get Funding Increase from Larger NHGRI Budget


WASHINGTON--A 20 percent spending increase for the National Human Genome Research Institute (NHGRI), approved as part of a $2 billion US National Institutes of Health funding increase in the 1999 federal budget package, will go largely to support advanced technological developments that will assist the Human Genome Project. Developing strength in bioinformatics and computational biology is one of eight main goals described in the project's new five-year plan, which was published in the October 23 issue of Science.

Elke Jordan, deputy director of NHGRI and coauthor of the plan, which calls for completion of the sequence by 2003, two years ahead of previous projections, told BioInform that it was written "with the assumption that the budget would be similar to what it finally came out to be." NHGRI's total 1999 budget is $265 million.

The plan calls for substantial investment in five key areas related to database and analytical tools development: improved content and utility of databases; developing better tools for data generation, capture, and annotation; developing and improving tools and databases for comprehensive functional studies; developing and improving tools for representing and analyzing sequence similarity and variation; and creating mechanisms to support effective approaches for producing robust, exportable software that can be widely shared.

New money, however, will go first to human sequencing efforts, Jordan said, explaining, "It was because of the anticipated increase that we were able to say we would be able to finish the human sequence earlier." She added that improvements in efficiency and throughput in sequencing labs are other significant factors enabling a faster finish.

Jordan continued, "In addition to sequencing, which is heavily dependent on bioinformatics, we are also moving into other new bioinformatics-dependent areas." For instance, she said, the project will begin to explore how sequence variation among individuals relates to health and disease. "That will require very different kinds of informatics products to study," she contended, adding, "We're also going into technology development for functional DNA analysis."

According to Jordan, NHGRI will spend another "chunk of money" to underwrite advanced development by industry or academic groups of prototype-stage technology. Candidates for the grant program, slated to begin next year, will be inventors of products that "will improve some step or other in the sequencing process" but that need further development to be introduced into a large-scale, high-throughput operation, she explained. She cited as an example new technology that will go "even beyond the capillary gel electrophoresis instruments," such as Perkin-Elmer's popular new ABI 3700 DNA analyzer. Jordan added, "There are a number of interested parties in companies that are looking forward to us announcing this program."

--Adrienne Burke

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.